Retrovirus promoter-trap vectors will be employed as insertional mutagens to isolate genes which prevent activated ras oncogenes from transforming cultured cells. The vector expresses an activated ras oncogene and also contain histidinol dehydrogenase (his) coding sequences inserted into the 3' long terminal repeat (LTR). His sequences do not interfere with virus replication or integration. Thus, when the virus is passaged, duplication of the LTRs places his sequences in the 5'LTR just 30 nt. from the flanking cellular DNA. Selection for histidinol resistance generates cell clones in which the provirus has integrated downstream of transcriptionally active promoters, disrupting cellular genes in the process. Cells which resist transformation by ras oncogenes (because of genetically dominant activities) will by infected by U3HisTKras and 104 -105 independent histidinol resistant clones (representative of all expressed sites) will be isolated, and pools of clones will be injected into nude mice. Transformants which emerge will be analyzed to determine if genes which normally prevent ras from transforming were disrupted as a result of provirus integration. Retrovirus promoter-trap vectors will also be used to analyze transcriptional control by growth factors, oncogenes and antioncogenes. The strategy uses promoter-trap retroviruses to force the integration of a reporter gene or selectable marker into a large collection of chromosomal sites and selecting for clones in which expression of the transduced marker gene is regulated by growth factors, by the myc and E1A oncogenes and by the Rb1 and WT1 anti-oncogenes. Genes inserted in U3 which permit selections both for and against expression (xanthine-guanine phosphoribosyltransferase, thymidine kinase, CD4) are expected to facilitate the isolation of cell clones in which the provirus has become linked to regulated promoters. Cellular sequences flanking proviruses will be amplified by polymerase chain reaction, cloned and analyzed for promoter elements and disrupted genes. Finally, cell lines containing provirus reporter genes fused to promoters which are regulated by growth factors, oncogenes or anti-oncogenes will be used to develop biological assays for functional studies of transcription factors encoded by oncogene and anti-oncogene proteins and of signal transduction pathways which regulate transcription.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA042063-10
Application #
3730664
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Gao, Ang; Shrinivas, Krishna; Lepeudry, Paul et al. (2018) Evolution of weak cooperative interactions for biological specificity. Proc Natl Acad Sci U S A 115:E11053-E11060
Dubbury, Sara J; Boutz, Paul L; Sharp, Phillip A (2018) CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nature 564:141-145
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Sabari, Benjamin R; Dall'Agnese, Alessandra; Boija, Ann et al. (2018) Coactivator condensation at super-enhancers links phase separation and gene control. Science 361:
Chiu, Anthony C; Suzuki, Hiroshi I; Wu, Xuebing et al. (2018) Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP. Mol Cell 69:648-663.e7
Mori, Munemasa; Hazan, Renin; Danielian, Paul S et al. (2017) Cytoplasmic E2f4 forms organizing centres for initiation of centriole amplification during multiciliogenesis. Nat Commun 8:15857
Braun, Christian J; Stanciu, Monica; Boutz, Paul L et al. (2017) Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma. Cancer Cell 32:411-426.e11
Tammela, Tuomas; Sanchez-Rivera, Francisco J; Cetinbas, Naniye Malli et al. (2017) A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545:355-359
Sasi, Nanda Kumar; Bhutkar, Arjun; Lanning, Nathan J et al. (2017) DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways. Neoplasia 19:439-450
JnBaptiste, Courtney K; Gurtan, Allan M; Thai, Kevin K et al. (2017) Corrigendum: Dicer loss and recovery induce an oncogenic switch driven by transcriptional activation of the oncofetal Imp1-3 family. Genes Dev 31:1066

Showing the most recent 10 out of 218 publications